Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0YO0R
|
|||
Former ID |
DNC013205
|
|||
Drug Name |
2-benzyl-N1-hydroxy-N3-(4-phenylbutyl)malonamide
|
|||
Synonyms |
CHEMBL220996; 2-benzyl-N1-hydroxy-N3-(4-phenylbutyl)malonamide; BDBM50197497
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H24N2O3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CCCCNC(=O)C(CC2=CC=CC=C2)C(=O)NO
|
|||
InChI |
1S/C20H24N2O3/c23-19(21-14-8-7-11-16-9-3-1-4-10-16)18(20(24)22-25)15-17-12-5-2-6-13-17/h1-6,9-10,12-13,18,25H,7-8,11,14-15H2,(H,21,23)(H,22,24)
|
|||
InChIKey |
WBIXUIDQAJRMSZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Aminopeptidase N (ANPEP) | Target Info | Inhibitor | [1] |
BioCyc | Glutathione-mediated detoxification | |||
KEGG Pathway | Glutathione metabolism | |||
Metabolic pathways | ||||
Renin-angiotensin system | ||||
Hematopoietic cell lineage | ||||
Pathwhiz Pathway | Glutathione Metabolism | |||
Pathway Interaction Database | C-MYB transcription factor network | |||
Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
WikiPathways | Metabolism of Angiotensinogen to Angiotensins | |||
Cardiac Progenitor Differentiation | ||||
miR-targeted genes in squamous cell - TarBase | ||||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
miR-targeted genes in leukocytes - TarBase | ||||
Glutathione metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents. J Med Chem. 2007 Mar 22;50(6):1322-34. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.